Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Ramipril - Generic Drug Details

« Back to Dashboard

What are the generic sources for ramipril and what is the scope of ramipril patent protection?

is the generic ingredient in two branded drugs marketed by West-ward Pharms Int, King Pharms, Aurobindo Pharma Ltd, Cipla, Actavis Elizabeth, Sandoz, Apotex, King Pfizer, Lupin, Zydus Pharms Usa, Invagen Pharms, Ranbaxy Labs Ltd, Watson Labs, Mylan Pharms Inc, Apotex Inc, Teva Pharms, Dr Reddys Labs Ltd, Accord Hlthcare, and Zydus Pharms Usa Inc, and is included in nineteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ramipril has forty-three patent family members in thirty-one countries.

There are nineteen drug master file entries for ramipril. Thirty-seven suppliers are listed for this compound.

Summary for Generic Name: ramipril

Drug Master File Entries: see list19
Suppliers / Packagers: see list37
Bulk Api Vendors: see list65
Clinical Trials: see list33
Patent Applications: see list6,488
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ramipril at DailyMed

Pharmacology for Ingredient: ramipril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
CAPSULE;ORAL091604-004Jun 8, 2011ABRXNoNo► Subscribe► Subscribe
CAPSULE;ORAL077004-004Aug 7, 2008DISCNNoNo► Subscribe► Subscribe
Watson Labs
CAPSULE;ORAL076549-003Oct 24, 2005ABRXNoNo► Subscribe► Subscribe
CAPSULE;ORAL077626-004Jun 9, 2008ABRXNoNo► Subscribe► Subscribe
King Pharms
CAPSULE;ORAL019901-002Jan 28, 1991ABRXYesNo7,368,469► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus